PERSONALIS INC

NASDAQ: PSNL (Personalis, Inc.)

Last update: 29 Nov, 8:33AM

10.73

0.01 (0.09%)

  • 1D 0.09%
  • 5D 0.00%
  • 1M 24.33%
  • 6M 98.70%
  • YTD 71.13%
  • 1Y 167.92%
  • 5Y -68.84%
Previous Close 10.72
Open 10.80
Volume 460,442
Avg. Volume (3M) 1,306,273
Market Cap 952,870,656
Price / Sales 11.67
Price / Book 4.95
52 Weeks Range
2.83 (-73%) — 11.40 (6%)
Earnings Date 4 Nov 2025
Profit Margin -98.10%
Operating Margin (TTM) -85.88%
Diluted EPS (TTM) -1.29
Quarterly Revenue Growth (YOY) 5.50%
Total Debt/Equity (MRQ) 21.81%
Current Ratio (MRQ) 6.91
Operating Cash Flow (TTM) -42.70 M
Levered Free Cash Flow (TTM) -23.09 M
Return on Assets (TTM) -17.90%
Return on Equity (TTM) -51.25%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Personalis, Inc. Bullish Bullish

AIStockmoo Score

0.3
Analyst Consensus 1.5
Insider Activity -1.5
Price Volatility -5.0
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average 0.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
PSNL 953 M - - 4.95
ICLR 14 B - 24.22 1.52
OPK 1 B - - 0.790
FLGT 954 M - - 0.760
MYGN 711 M - - 1.90
PRE 227 M - - 1.50

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Value
% Held by Insiders 31.49%
% Held by Institutions 46.11%

Ownership

Name Date Shares Held
Merck & Co., Inc. 30 Sep 2025 14,044,943
52 Weeks Range
2.83 (-73%) — 11.40 (6%)
Price Target Range
10.00 (-6%) — 13.00 (21%)
High 13.00 (HC Wainwright & Co., 21.16%) Buy
Median 12.00 (11.84%)
Low 10.00 (Needham, -6.80%) Buy
Average 11.60 (8.11%)
Total 4 Buy, 1 Hold
Avg. Price @ Call 8.62
Firm Date Target Price Call Price @ Call
Morgan Stanley 02 Dec 2025 11.00 (2.52%) Hold 10.10
11 Nov 2025 9.00 (-16.12%) Hold 8.44
BTIG 11 Nov 2025 12.00 (11.84%) Buy 8.44
22 Oct 2025 11.00 (2.52%) Buy 8.93
Guggenheim 11 Nov 2025 12.00 (11.84%) Buy 8.44
HC Wainwright & Co. 11 Nov 2025 13.00 (21.16%) Buy 8.44
06 Nov 2025 10.00 (-6.80%) Buy 7.19
Needham 05 Nov 2025 10.00 (-6.80%) Buy 7.66
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
TACHIBANA AARON - 11.21 -103,668 -1,162,118
Aggregate Net Quantity -103,668
Aggregate Net Value ($) -1,162,118
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 11.21
Name Holder Date Type Quantity Price Value ($)
TACHIBANA AARON Officer 25 Nov 2025 Automatic sell (-) 103,668 11.21 1,162,118
TACHIBANA AARON Officer 25 Nov 2025 Option execute 103,668 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria